Talaris Therapeutics goes public

Boston-based Talaris Therapeutics Inc, a cell therapy company, has raised about $150 million for its IPO after pricing its over 8.8 million shares at $17 per share.

7 May 2021•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail